Skip to main content
. Author manuscript; available in PMC: 2018 Dec 1.
Published in final edited form as: J Clin Anesth. 2017 Sep 30;43:24–32. doi: 10.1016/j.jclinane.2017.09.008

Table 5.

Outcome measures for patients undergoing total hip replacement according to primary payer group.

Characteristic Medicare (%) Medicaid (%) Private
Insurance (%)
Other (%) Uninsured (%) Overall (%) P-value
In-hospital mortality
   No 164,495 (99.7) 10,150 (99.8) 110,093 (99.9) 8,015 (99.9) 2,301 (100.0) 295,054 (99.8) <.0001
   Yes 415 (0.3) 17 (0.2) 51 (0.0) <11 <11
   Missing 17 (0.0) <11 <11 <11
Any complication 12,006 (7.3) 624 (6.1) 4,488 (4.1) 410 (5.1) 144 (6.3) 17,672 (6.0) <.0001
Cardiovascular complications grouped variable 3,529 (2.1) 114 (1.1) 895 (0.8) 73 (0.9) 30 (1.3) 4,641 (1.6) <.0001
Pulmonary complications grouped variable 4,613 (2.8) 281 (2.8) 2,023 (1.8) 206 (2.6) 57 (2.5) 7,180 (2.4) <.0001
Infectious complications grouped variable 3,735 (2.3) 225 (2.2) 1,113 (1.0) 108 (1.3) 48 (2.1) 5,229 (1.8) <.0001
Intraoperative complication grouped variable 1,078 (0.7) 71 (0.7) 475 (0.4) 36 (0.4) 17 (0.7) 1,677 (0.6) <.0001
Gastrointestinal complication 988 (0.6) 40 (0.4) 420 (0.4) 32 (0.4) <11 <.0001
90-Day Readmission** 18,444 (11.9) 1,320 (14.5) 7,461 (7.3) 676 (9.3) 174 (9.2) 28,075 (10.2)
Length of stay: Median (Q1; Q3) 3 (3; 4) 4 (3; 5) 3 (3; 4) 3 (3; 4) 3 (3; 4) 3 (3; 4) <.0001
Total charges in 2016 dollars: Median (Q1; Q3) 64,495 (48,110; 87,804) 66,561 (45,716; 92,108) 63,054 (47,780; 85,612) 68,924 (49,631; 93,172) 57,897 (39,947; 78,428) 64,080 (47,895; 87,280)

Percents may not sum to 100 due to rounding and missing values.